However, if EDAR signalling had only a simple and positive relationship with β-catenin activity, then it is difficult to explain the observed selection for somatic mutations in CTNNB1 that produce an activated β-catenin protein in tumours of the EdarTg951/951 line. This evidence concerns the gene CTNNB1 and neoplasm.